European Archives - Page 2 of 1188 - European Medical Journal

Patient Advocacy in Huntington's: Interview with Astri Arnesen

It all began when my mother was diagnosed with Huntington’s disease. At the time, Huntington’s was a rare disease, and it still is by…

HLTH Europe 2025 Interview: Aiga Balode

Aiga Balode – Deputy State Secretary for Digitalization and Change Management, Ministry of Health of the Republic of Latvi – During the…

Differences in Hepatitis B Virus- and Alcohol-Related Liver Failure

The study highlights stark contrasts in ACLF triggers across regions: HBV predominates in Eastern countries such as China, while alcohol is the main culprit in the West.

Age, Genetics, and Kidney Function Influence Dementia Blood Biomarkers

Parental genetics and kidney function partly shape blood-based biomarkers for dementia, underscoring the need for careful interpretation.

HLTH Europe 2025 Interview: Miles Payling

At C the Signs, our mission is to give everyone the chance to survive their cancer diagnosis. The best way to achieve this is through early…

Interview: Lucilla Piccari

Some of the most interesting data are precisely those illustrating the reality of clinical practice of physicians attending patients…

New Genetic Clues Link Chronic Cough and ACE Inhibitors

Scientists uncover shared genetic signals between chronic dry cough and ACE inhibitor-induced cough, pointing to neurological pathways as potential targets.

Eight Babies Born After Mitochondrial Donation in Groundbreaking IVF Procedure

A landmark study confirms the success of mitochondrial donation via pronuclear transfer, with eight healthy babies born free of inherited mtDNA disease.

Heart Biomarkers Linked to Higher Cancer Risk

Higher levels of two cardiac biomarkers at baseline are associated with an increased risk of future cancer…

No Survival Difference in Patients with Both Lung Cancer and Rheumatoid Arthritis

A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune checkpoint inhibitors…